This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Glaxosmithkline Biologicals Sa, Glaxosmithkline Intellectual Property Development Limited. Active years: 2021.
Company Filing History:
1 out of 545 
1 out of 242 
Years Active: 2021
Title: David Mayhew: Innovator in Immunogenic Compositions
Introduction
David Mayhew is a notable inventor based in Collegeville, PA (US). He has made significant contributions to the field of immunology, particularly in the treatment of chronic obstructive pulmonary disease (COPD). His innovative work has led to the development of a patent that addresses critical health issues.
Latest Patents
David Mayhew holds a patent for an immunogenic composition, which includes an immunogenic polypeptide and its fragments. This invention is aimed at treating or preventing the recurrence of acute exacerbations of chronic obstructive pulmonary disease (AECOPD) caused by bacterial infections. His work in this area is vital for improving patient outcomes and advancing medical treatments.
Career Highlights
Throughout his career, David has worked with prominent organizations, including GlaxoSmithKline Intellectual Property Development Limited and GlaxoSmithKline Biologicals SA. His experience in these companies has allowed him to contribute to significant advancements in pharmaceutical research and development.
Collaborations
David has collaborated with esteemed colleagues, including Catherine Cohet and Jeanne-Marie Josephine Devaster. These partnerships have fostered a collaborative environment that enhances innovation and research in the field of immunology.
Conclusion
David Mayhew's contributions to immunogenic compositions demonstrate his commitment to advancing medical science. His patent and collaborations reflect his dedication to improving health outcomes for individuals suffering from chronic respiratory conditions.